Does Indication-Specific Pricing Fit Generics With Carveouts?
Indication-specific pricing (ISP) is often proposed as a solution to rising health care costs, particularly for branded drugs that have multiple indications. But it is unclear whether such a model could...To view the full article, register now.
Already a subscriber? Click here to view full article